全球心臟影像软体市场规模（依显像模式、最终用户、应用、地区、预测）- 2020 年

心臟影像软体市场规模与预测

2024 年心臟影像软体市场规模价值为 5.0413 亿美元，预计到 2032 年将达到 9.0681 亿美元，在 2026-2032 年预测期内的复合年增长率为 8.40%。

由于影像设备技术的进步、人口老化以及心血管手术的增加，全球心臟影像软体市场预计将持续成长。心臟影像软体市场报告对市场进行了全面的评估，包括关键细分市场、趋势、市场驱动因素、限制因素、竞争格局以及影响市场的关键因素。

全球心臟影像软体市场概况

心血管疾病 (CVD) 盛行率的上升是全球住院的主要原因之一。据世界卫生组织称，CVD 是全球最大的死亡原因，估计每年夺走 1800 万人的生命。由于心血管疾病的发生率不断上升，对使用 MRI、 电脑断层扫描、血管造影术、放射化学物质和其他同步辐射来识别心臟相关问题的心臟影像软体的需求也日益增长。此外，老年人口的成长、技术进步、CT、PET 等心臟影像方式的使用增加、心血管疾病的根本原因增加以及市场参与企业针对这些因素制定的发展计划等因素预计将使全球心臟影像软体市场受益。

高成本主要是因为现代技术成本高昂、诊断测试的大量使用以及药理学和医学治疗。在美国，诊断影像费用每年超过 1000 亿美元。心血管影像 (CVI) 占总诊断影像负担的 29%，占全球每年进行的数十亿次诊断影像测试的至少三分之一。此外，这是由于专有软体产品的结合以及与其他软体和硬体提供者的互通性。而且，各个供应商之间并不统一。这使得进行多中心、基于人群的研究变得困难，因为数据可能来自不同供应商生产的设备。因此，预计全球心臟影像软体市场的成长将放缓。

目录

第一章 引言

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 市场概述

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章。心臟影像软体市场（以显像模式）

• 概述
• 电脑断层扫描
• 磁振造影
• 超音波影像
• X射线影像
• 多模态

第六章心臟影像软体市场（按最终用户）

• 概述
• 医院和诊所
• 诊断中心
• 其他的

第七章心臟影像软体市场（按应用）

• 概述
• 影像学诊断
• 影像导引治疗
• 病患监测

第八章心臟影像软体市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争态势

• 概述
• 各公司市场排名
• 主要发展策略

第十章 公司简介

• Shimadzu Corporation
• Koninklijke Philips NV
• Siemens AG
• Canon Inc.
• Agfa-Gevaert Group
• General Electric
• Circle Cardiovascular
• Fujifilm Holdings Corporation
• Symphony Innovations, LLC
• Pie Medical Imaging

第十一章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十二章 附录

• 相关调查

Cardiac Imaging Software Market Size And Forecast

Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.

The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Cardiac Imaging Software Market Size And Forecast

Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.

The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cardiac Imaging Software Market Overview

The rising prevalence of cardiovascular diseases (CVD) is one of the primary reasons for hospitalization worldwide. According to WHO, CVDs are the leading cause of mortality worldwide, claiming an estimated 18 million lives each year. As a result of the increased frequency of cardiovascular disorders, there is a greater need for cardiac imaging software to identify heart-related issues using MRI, CT scan, angiography, radioactive chemicals, and other types of radiant light. Furthermore, factors such as an increase in the older population, technological improvements, and increased use of cardiac imaging modalities such as CT, PET, and others, a Rise in underlying causes of cardiovascular disease, and market participants' development plans of these factors are projected to benefit the worldwide Cardiac Imaging Software Market.

The high cost is mostly due to the high expense of contemporary technology, the extensive use of diagnostic tests, and pharmacological and medical therapies. In the United States, imaging expenses surpass USD 100 billion each year. Cardiovascular imaging (CVI) accounts for 29 percent of the total imaging burden and at least one-third of the several billion medical imaging exams conducted worldwide each year. Furthermore, this was ascribed in part to proprietary software products and their built-in interoperability with other software and hardware providers. Furthermore, there is a lack of uniformity across providers. This makes multi-site, population-based research challenging to conduct, as data may be acquired from gear produced by various suppliers. This is projected to slow the global Cardiac Imaging Software Market's growth.

Global Cardiac Imaging Software Market Segmentation Analysis

The Global Cardiac Imaging Software Market is Segmented on the basis of Imaging Modalities, End-User, Application, and Geography.

Cardiac Imaging Software Market, By Imaging Modalities

• Computed Tomography
• Magnetic Resonance
• Ultrasound Imaging
• X-Ray Imaging
• Combined Modalities

Based on Imaging Modalities, the market is segmented into Computed Tomography, Magnetic Resonance, Ultrasound Imaging, X-Ray Imaging, and Combined Modalities. The computed tomography sector is predicted to increase at a healthy rate over the projection period because it is more efficient than conventional X-rays at delivering doses of cancer-damaging radiation.

Cardiac Imaging Software Market, By End-User

• Hospital & Clinics
• Diagnostic Centers
• Others

Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. The market has seen a dramatic surge in the number of patients suffering from cardiovascular illnesses such as coronary heart disease, heart attacks, strokes, congenital heart disease, and others during the previous few years. The number of hospitals worldwide is steadily rising as the number of patients increases. By end-user, hospitals and clinics dominate the worldwide Cardiac Imaging Software Market. This share is mostly due to an increase in the number of individuals being monitored for a heart condition.

Cardiac Imaging Software Market, By Application

• Diagnostic Imaging
• Image Guided Treatment
• Patient Monitoring

Based on Application, the market is segmented into Diagnostic Imaging, Image Guided, and Patient Monitoring.

Cardiac Imaging Software Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the Global Cardiac Imaging Software Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America Americas accounted for the majority of the global market because of the high prevalence of cardiovascular diseases, technological advancements, high disposable income, a growing older population, and a favorable regulatory environment. The rise in the frequency of heart diseases is linked to North America's dominance.

Key Players

The "Global Cardiac Imaging Software Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Shimadzu Corporation, Koninklijke Philips NV, Siemens AG, Canon Inc., Agfa-Gevaert Group, General Electric, Circle Cardiovascular, Fujifilm Holdings Corporation, Symphony Innovation, LLC, and Pie Medical Imaging.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• In June 2021, Circle Cardiovascular Imaging Inc. (Canada) formed an alliance with DiA Imaging Analysis (Israel). This collaboration will provide clients with all-in-one complete Ai-based cardiovascular imaging solutions, as well as new potential in multi-modality imaging solutions for physicians, patients, and hospitals globally. Circle's cardiac imaging offering will be strengthened by DiA's FDA-cleared and CE-marked LVivo Toolbox, a series of breakthrough AI-based cardiac ultrasound products.
• In June 2021, GE Healthcare (US) partnered with the American College of Cardiology (US) to develop artificial intelligence and digital health technology in cardiology.
• In March 2021, TeraRecon, one of the top healthcare imaging AI technology businesses, has been acquired by Symphony Innovation, LLC (US). Symphony AI Group has begun its new range of healthcare AI solutions centered on medical imaging with this purchase.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARDIAC IMAGING SOFTWARE MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CARDIAC IMAGING SOFTWARE MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY IMAGING MODALITY

• 5.1 Overview
• 5.2 Computed Tomography
• 5.3 Magnetic Resonance
• 5.4 Ultrasound Imaging
• 5.5 X-Ray Imaging
• 5.6 Combined Modalities

6 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals & Clinics
• 6.3 Diagnostics Centers
• 6.4 Others

7 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 Diagnostic Imaging
• 7.3 Image Guided Treatment
• 7.4 Patient Monitoring

8 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL CARDIAC IMAGING SOFTWARE MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Shimadzu Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Koninklijke Philips NV
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Siemens AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Canon Inc.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Agfa-Gevaert Group
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 General Electric
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Circle Cardiovascular
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Fujifilm Holdings Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Symphony Innovations, LLC
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Pie Medical Imaging
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research